T-helper Type 1 and 2 Cytokine Levels in Patients with Benign and Malignant Salivary Gland Tumors
<b>Background</b>: Salivary gland tumors are among malignancies that have high recurrence rate. Immune responses in salivary gland tumors have not been well elucidated. T helper type 1 (Th1) and Th2 cytokines have been reported to play a role in the outcome of head and neck cancers. <...
Main Authors: | Bijan Khademi, Marziyeh Tajvarpour, Zahra Mojtahedi, Mohammad Reza Haghshenas, Nasrollah Erfani |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2016-03-01
|
Series: | Iranian Journal of Immunology |
Online Access: | http://iji.sums.ac.ir/article_16723_c598b1cd81b4181b76617fb24f8ecdaa.pdf |
Similar Items
-
MTA1 Expression in Benign and Malignant Salivary gland Tumors
by: Azadeh Andisheh-Tadbir, et al.
Published: (2016-01-01) -
Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
by: Naghmeh Jeiroodi, et al.
Published: (2017-07-01) -
A benign salivary gland tumor of minor salivary gland mimicking an epithelial malignancy
by: Vandana Reddy, et al.
Published: (2015-01-01) -
Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
by: Azadeh Andisheh–Tadbir, et al.
Published: (2019-11-01) -
Expression of maspin in benign and malignant salivary gland tumor
by: Sim Sai Tin, et al.
Published: (2016-01-01)